首页> 外文会议>International Conference on Cyber and IT Service Management >Protecting Consumers from Misleading Online Advertisement for Herbal and Traditional Medicines in Malaysia: Are the Laws Sufficient?
【24h】

Protecting Consumers from Misleading Online Advertisement for Herbal and Traditional Medicines in Malaysia: Are the Laws Sufficient?

机译:保护消费者免受马来西亚中草药和传统药物的误导性:法律是否足够?

获取原文

摘要

Herbal supplements and traditional medicines have become very popular among consumers as part of treatment for diseases as well as to improve general health and well-being. Manufacturers and producers of these products are now taking the benefits of the internet to market them as they could easily reach a large number of potential buyers and end-users. In fact, internet advertising has globally become one of the favourite models of advertising with the rise of digital equipment and media in particular smart phones and other gadgets which enable access to the internet. The problem arises when some online advertisements including those published on social media are found to be illegal, misleading and deceptive as it contains inter alia, dubious or unproven claims in relation to the use and efficacy of herbal and traditional medicines. From regulatory perspective, all type of dissemination of information about products and health services including to market the products online are classified as advertisement. In Malaysia, the approval from Medicine Advertisements Board (MAB) under the Ministry of Health (MOH) is required before the advertisement can be published to the public. This paper uses doctrinal legal research method in examining the current issues and challenges revolving around illegal and misleading advertisements of herbal and traditional medicines. It then proceeds to discuss the relevant regulatory framework to address those issues, in particular the important role played by MAB. Relevant legislations from Australia, United States (US) and European Union (EU) are also explored for the purpose of emulating best practices with a view to enhance the existing legal mechanism in Malaysia. The paper concludes with some suggestions to further tighten up some of the provisions in particular the enforcement and monitoring mechanism so that consumers will be better protected from unscrupulous and irresponsible online advertisements.
机译:草药补充剂和传统药物已成为深受消费者喜爱作为治疗的一部分用于疾病以及改善整体健康和福祉。制造商和这些产品的生产商现在正在向市场推出他们的互联网的好处,因为他们可以很容易地接触到大量的潜在买家和最终用户的。事实上,互联网广告已经成为全球的数字设备,特别是智能手机和其他小工具媒体的兴起广告的喜爱的车型,其能够访问互联网的一个。当一些在线广告包括社交媒体上公布被发现是非法的,误导和欺骗性,因为它含有特别是在关系到草药和传统药物的用途和功效可疑的或未经证实的要求,就会出现问题。从监管的角度来看,所有类型的产品和健康服务,包括网上市场的产品信息传播被列为广告。在马来西亚,需要从卫生部(MOH)下的医药广告板(MAB)批准前的广告可以发布给公众。本文采用在检查当前问题教义的法律研究方法和各种挑战旋转围绕非法的和误导的草药和传统药物的广告。然后继续讨论相关的监管框架,以解决这些问题,特别是人与生物圈计划发挥的重要作用。来自澳大利亚,美国(美国)和欧盟(EU)有关法律法规,也探讨了模仿的最佳做法,以加强在马来西亚现有的法律机制的目的。本文提出一些建议总结,以进一步收紧一些,特别是执法和监测机制的规定,使消费者免受不道德和不负责任的在线广告得到更好的保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号